In brief
On November 7, 2026, WHO launched a new collaborating center for STI prevention and innovation in Guangzhou, China. The center, hosted by Southern Medical University, will train specialists, develop point‑of‑care testing tools and create a surveillance data platform. While the center has clear objectives and ambitious targets, its ultimate impact and operational details remain to be seen.
The World Health Organization formally opened a new Collaborating Center for Sexually Transmitted Infection Prevention and Innovations in Guangzhou, southern China, on Saturday, November 7, 2026, as a joint effort of the Dermatology Hospital of Southern Medical University and the SMU Institute for Global Health.
Yang Bin, the center’s director, described the facility as a hub for systematic, forward‑looking international cooperative research, with a focus on capacity building, testing innovation and surveillance system development.
With a longer‑term vision, the center plans to lead the creation of a standardized training series and, by 2030, train 100 senior STI prevention and control professionals in 15 low‑ and middle‑income countries. The training priority will be Africa and Southeast Asia, the regions that WHO identified as having the greatest need for strengthened STI services.
“We will develop three to five practical, scalable strategies to optimise point‑of‑care testing,” Yang Bin said, outlining the center’s research agenda toward making STI diagnostics more accessible and affordable in resource‑constrained settings.
On the surveillance front, the center will produce standardized, simple data‑collection tools for STI surveillance, conduct pilot verification and localised application in selected African countries, and build an operational data integration and sharing platform that can interoperate with international health information systems.
Hannah Monica Dias of WHO commented that the new center would deepen its engagement in developing relevant international guidelines, contribute more research evidence, support STI surveillance and capacity building across countries on a global scale, and provide expert advice to strengthen public health governance.
China’s participation reflects a broader multilateralist stance. In 2025, Chinese medical personnel were dispatched to 57 countries, serving more than 2.06 million patients, and the country also supported malaria control efforts in Africa and Southeast Asia. Under the China–WHO Country Cooperation Strategy for 2022–2026, the two sides expanded cooperation through pilots of people‑centered integrated health‑care delivery systems in China and successful support for Cambodia and Laos in the elimination of schistosomiasis.
While the center’s mandate is broad, it faces several practical questions, chief among them whether the training targets can be met within the projected timeframe, how effectively the point‑of‑care testing strategies will be adopted in target regions, and whether the surveillance platform will achieve interoperability with existing national and international data systems.
These uncertainties are acknowledged by the sources themselves, who highlight that the center’s success will largely depend on sustained partnerships, adequate funding, and real‑world pilot testing across diverse settings before scaling up to the global agenda.
